The 20 Best Teratocarcinosarcoma Doctors Near Me in Ann Arbor, MI

Additional Credentials:Division Chief, Rhinology and Skull Base SurgeryUniversity of Michigan Ross School of Business, 2012. Dr. Mckean is rated as an Elite provider by MediFind in the treatment of Teratocarcinosarcoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Olfactory Neuroblastoma, Teratocarcinosarcoma, Sinus Cancer, Balloon Sinuplasty, and Turbinectomy. Dr. Mckean is board certified in Otolaryngology-Head & Neck Surgery.

Scott Mclean is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Mclean is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Teratocarcinosarcoma, Sinus Cancer, Tissue Biopsy, and Laryngectomy. Dr. Mclean is board certified in Otolaryngology-Head & Neck Surgery.

Dr. Mierzwa has 8 years of clinical experience in treatment of head and neck as well as gastrointestinal cancers. Her clinical research interests have included novel chemoradiation regimens for head and neck cancers as well as pancreatic cancer. Specifically, she is currently in collaboration with the Department of Otolaryngology as part of a clinical trial to identify radiographic and serum biomarkers for oropharynx cancer patients who may be eligible for de-escalation of chemoradiation. Dr. Mierzwa is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Dry Mouth, and Pancreaticoduodenectomy. Dr. Mierzwa is board certified in Radiation Oncology.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Dr. Chaz Stucken is an associate professor of otolaryngology- head & neck surgery at the University of Michigan. He is dual-fellowship trained in both head & neck cancer surgery as well as facial plastic & reconstructive surgery. Dr. Stucken completed an accelerated 7-year B.A./M.D. at Boston University, earning his M.D. in 2008. He subsequently completed his training in otolaryngology-head & neck surgery at The Mount Sinai Hospital in New York City, where he received the Chairman’s Award at the completion of residency. Dr. Stucken then earned sub-specialty fellowship training in head & neck oncologic & microvascular surgery at the University of Michigan and in Facial Plastic & Reconstructive Surgery at Ohio State University. Throughout his training, Dr. Stucken received awards for excellence in research and clinical care. He has published several book chapters and scholarly articles in otolaryngology texts and peer-reviewed journals. Dr. Stucken is involved in humanitarian outreach work and has traveled to Guatemala to perform cleft lip surgery. He is dedicated to serving Spanish-speaking patients in southeast Michigan. He has given numerous presentations at conferences around the country, taught at instructional courses for other surgeons, and has been an invited faculty member to symposium on facial plastic & reconstructive surgery. He is an active member of the American Academy of Otolaryngology- Head & Neck Surgery and the American Academy of Facial Plastic & Reconstructive Surgery. He serves on several national committees including the Plastic & Reconstructive Surgery Committee, Microvascular Surgery Committee, and Humanitarian Efforts Committee.Dr. Stucken is committed to providing the highest level of care to his patients. He is also working to discover medical and surgical breakthroughs by collaborating with other surgeons and researchers throughout the medical center. He works closely with cutaneous oncology surgeons to provide optimal skin cancer treatments and reconstruction. As a member of the Comprehensive Head & Neck Cancer Team, he works closely with medical oncologists and radiation oncologists and enrolls patients in the most advanced clinical trials. Surgically, his subspecialty training gives him the opportunity to provide specialized care for every patient in order to obtain the best possible outcomes. Dr. Stucken is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Melanoma, Laryngectomy, and Tissue Biopsy. Dr. Stucken is board certified in Otolaryngology-Head & Neck Surgery and Facial Plastic & Recon Surg.

Leslie Fecher, MD, joined the faculty on from Indiana University School of Medicine's Simon Cancer Center. Dr. Fecher completed her BA in Biochemistry at Rice University in Houston, and earned her MD from Indiana University School of Medicine. She completed her residency at University of Texas Southwestern in Dallas, followed by an Oncology Fellowship at Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center in Baltimore. Dr. Fecher was an assistant professor of medicine at the Abramson Cancer Center in Philadelphia for four years where she held a secondary appointment in Dermatology. She subsequently joined the faculty at Indiana University in 2011. Dr. Fecher is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Tissue Biopsy.

Paul Swiecicki is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Swiecicki is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Oral Squamous Cell Carcinoma. Dr. Swiecicki is board certified in Medical Oncology.

Keith Casper is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Casper is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Glossectomy. Dr. Casper is board certified in Otolaryngology-Head & Neck Surgery.

Avraham Eisbruch is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Eisbruch is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Dry Mouth, Head and Neck Squamous Cell Carcinoma (HNSCC), and Glossectomy.

Christopher Lao is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Lao is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, and Metastatic Uveal Melanoma.

Amarbir Singh Gill, M.D. is an Assistant Professor of Otolaryngology and fellowship trained rhinologist and skull base surgeon. He obtained his medical degree from the George Washington University School of Medicine. Dr. Gill then completed his otolaryngology residency at the University of California Davis before heading to the University of Utah, where he completed a 2-year rhinology and skull base fellowship. He is board certified in otolaryngology.His clinical interest lies in the diagnosis and management of inflammatory sinus disease, including chronic sinusitis, as well as both sinonasal and skull base tumors, such as pituitary tumors masses, through the use of minimally invasive, endoscopic techniques. He values personalizing care to the needs and wants of each unique patient. Dr. Gill works closely with a multi-disciplinary team of neurosurgeons, head and neck surgeons and neuroradiologists to ensure the best treatment outcomes for his patients. He serves as a faculty member in Head and Neck Surgery. Dr. Gill is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Nasal Polyps, Endoscopy, and Septoplasty. Dr. Gill is board certified in Otolaryngology-Head & Neck Surgery.

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.

Paul Hoff is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Hoff is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Tonsillitis, Salivary Duct Stones, Glossectomy, and Endoscopy. Dr. Hoff is board certified in Otolaryngology-Head & Neck Surgery.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.

Dr. James Hayman received his medical and master of business administration degrees simultaneously from the University of Chicago in 1991. Following an internship in Evanston, Ill., he began his radiation oncology residency at the Joint Center for Radiation Therapy at Harvard Medical School. He joined the University of Michigan faculty immediately following his residency in 1996 and currently serves as the director of the Clinical Division of the Department of Radiation Oncology. Dr. Hayman's clinical interests include the management of lung, esophageal, breast and central nervous system malignancies. He is also active in the area of health services research. Dr. Hayman is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Melanoma of the Eye, Merkel Cell Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Hayman is board certified in Radiation Oncology and Hospice & Palliative Med.

Andrew G. Shuman, MD, FACS, HEC-C is a head & neck cancer surgeon and a tenured Professor at the University of Michigan Medical School. He serves as chief of the clinical ethics service for Michigan Bioethics.He is the Assistant Dean for Veterans Affairs University of Michigan Medical School and the Associate Chief of Staff-Education at the VA Ann Arbor Health System, where he directs the educational experience for 1600 pre- and post-doctoral trainees and learners.Dr. Shuman is internationally recognized as a thought leader in ethical issues arising within the field of otolaryngology and surgical oncology. His work involves defining the conceptual dimensions of “surgical ethics,” applying his perspective as a practicing surgeon and clinical ethicist to normative and empirical bioethics research. He received extramural research funding for his work from NIH, the VA and societal grants, and has a portfolio of publications in leading journals in the fields of ethics, oncology and otolaryngology including The New England Journal of Medicine, JAMA and Nature Medicine. He has acted as PI on projects focused on cancer treatment decision-making, precision oncology and drug shortages, tailored to directly inform both the clinical practice and legal regulation of these ethically contentious and clinically complex disciplines. He was closely involved in Michigan Medicine and the VA's pandemic response, as well as at the state and national level on the ethics of scarce resource allocation including testifying in front of the United States Senate.Dr. Shuman completed fellowships in head and neck surgical oncology at Memorial Sloan-Kettering Cancer Center, and in medical ethics at Weill Medical College of Cornell University. He completed his residency in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. He is a graduate of the University of Michigan Medical School, and also graduated from the University of Michigan's College of Literature, Science and the Arts. Dr. Shuman is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Salivary Gland Tumors, and Laryngectomy. Dr. Shuman is board certified in Otolaryngology-Head & Neck Surgery.

Dr. Mark Prince earned his medical degree at Dalhousie University Medical School in Halifax, Nova Scotia, and then served with the Canadian Armed Forces as a medical officer, receiving specialized training in hyperbaric and diving medicine. Dr. Prince returned to Dalhousie University and completed a residency in otolaryngology head and neck surgery, followed by a two-year fellowship in advanced head and neck oncology and microvascular reconstructive surgery at the University of Michigan. He joined the University of Michigan faculty in 2000, and is actively involved in resident and medical student education, serving as his department's residency program director. Dr. Prince served as the chief of the section of otolaryngology at the Ann Arbor VA Medical Center until 2009, he continues to serve there as an active staff member. His research laboratory published the first report of the identification of cancer stem cells in head and neck squamous cell cancer, and continues to conduct research in this exciting field. Dr. Prince is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, and Gastrostomy. Dr. Prince is board certified in Otolaryngology-Head & Neck Surgery.

Kelly Malloy is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Malloy is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Osteotomy.

Victoria Wytiaz is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Wytiaz is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Desmoid Tumor, Bone Tumor, Synovial Sarcoma, and Rhabdoid Tumor. Dr. Wytiaz is board certified in Pediatrics, Medical Oncology, and Internal Medicine.

Lawrence Marentette is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Marentette is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Cerebrospinal Fluid Leak, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, and Osteotomy.